Drugs / Trivalent Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05593042 | Nov 2022 → Oct 2023 | COVID-19 | Pontificia Universidad Catolica de Chile | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05593042 ↗ |
| Modality | Vaccine | “an inactivated trivalent (CZ02 strain, ancestral, Delta, and Omicron variants) variant vaccine” NCT05593042 ↗ |